US stock · figures in US dollars · scored on full-year results
Veeva Systems Veeva Systems Inc. Class A Common Stock
Veeva Systems scores 65/100 on fundamentals: in the top 22% of 503 scored S&P 500 stocks. Its strongest area is Financial Safety (100/100); its weakest is Price Fairness (0/100). It carries 2 warning flags: Weak Spot, Limited Data.
- Carries a Weak Spot flag
- Carries a Limited Data flag
A financially strong, expensively priced stock with healthy growth, but price fairness needs attention.
Nearby peers
Ranks #10 of 60 in Healthcare by score
One-Minute Summary
Why Veeva Systems scores 65
A financially strong, expensively priced stock with healthy growth, but price fairness needs attention.
Business Strength
90Why 90?
Show 3 charts
Net Profit & Equity, with ROE
Revenue & Net Profit, with Net Margin
Sales grew about 46.3% over 4 years: customers keep spending more with this company.
Profit climbed about 93% over 4 years: the business keeps more money as it grows.
Recent Quarters: Revenue & Net Profit (the last 8 quarters, scored)
Sales grew about 32.7% over the last 8 quarters: customers keep spending more with this company.
Profit grew about 47.1% over the last 8 quarters: the business is keeping more of what it earns.
Financial Safety
100Why 100?
No data: Interest Coverage
Show 2 charts
Debt vs Equity, with D/E ratio
Borrowings grew about 171.9% over 4 years: watch this; rising debt adds pressure in bad times.
Short-term assets vs bills, with Current Ratio
Cash & Dividends
75Why 75?
Show 2 charts
Cash vs Total Debt
Dividends per Share, with Yield
Dividends per share have been maintained or raised: management shares the rewards with you.
Price FairnessLowest pillar
0Why 0?
Show chart
Share Price: Weekly Closes (not part of the score)
The share price is up about 7.5% over the past year.
Risk
70Why 70?
No data: Inventory vs Sales (4yr)
Sector peers
Veeva Systems (VEEV) scores 65/100 (Okay) on Score Your Stock's educational fundamentals model: in the top 22% of 503 scored S&P 500 stocks.
Its strongest pillar is Financial Safety (100/100); its weakest is Price Fairness (0/100).
Veeva Systems ranks #10 of 60 scored Healthcare stocks on Score Your Stock.
Veeva Systems (VEEV) has not paid a dividend in the last 12 months.
From Malaysia, open an account with a broker that offers US shares (many local and app-based brokers do), convert ringgit to US dollars, then buy VEEV. US shares trade one share at a time, not in lots of 100. Check the currency conversion fee and US dividend tax (usually 30% withheld for Malaysians) before you buy.
The overall score pools every measure across 5 weighted pillars: Business Strength, Financial Safety, Cash & Dividends, Price Fairness, and Risk. It uses the same rules as our Bursa scores. For banks, Financial Safety checks nonaccrual (impaired) loans, loan loss coverage and the CET1 capital ratio, from the FDIC call report of the group's main bank. Full methodology and the default weights: https://scoreyourstock.com/how. This is an educational tool, not investment advice.
Veeva Systems (VEEV) is a Healthcare company (Health Information Services). On Score Your Stock's fundamentals check, it scores 65/100, rated Okay. Its biggest strength is Financial Safety (100/100); its main watch-out is Price Fairness (0/100). Shares currently cost about 50 years of its current profit to buy (P/E 49.9×). Full breakdown and daily-updated score: https://scoreyourstock.com/stocks/us/veev-veeva-systems
Full Financial History
Every reported figure behind the score, year by year. Download it, or check it against the company's own annual report.
| Financial Year | Revenue | Net Profit | Operating Cash Flow | Cash | Total Debt | Short-Term Debt | Equity | Current Assets | Current Liabilities | Total Assets | Total Liabilities | Dividends | Return on Equity (ROE) | Net Profit Margin | Debt-to-Equity | Current Ratio | Div yield | P/E Ratio | P/B Ratio | PEG Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2027 | US$ 3.5b | US$ 1.0b | US$ 1.7b | US$ 1.8b | US$ 151.7m | US$ 14.6m | US$ 7.4b | US$ 7.9b | US$ 1.5b | US$ 9.1b | US$ 1.6b | - | 14% | 29% | 0.0× | 5.5× | - | - | - | - |
| 2026 | US$ 3.2b | US$ 908.9m | US$ 1.4b | US$ 1.4b | US$ 95.9m | US$ 12.2m | US$ 7.2b | US$ 8.0b | US$ 1.6b | US$ 9.0b | US$ 1.8b | US$ 0.0m | 13% | 28% | 0.0× | 4.9× | 0% | 36.7× | 4.6× | 1.6 |
| 2025 | US$ 2.7b | US$ 714.1m | US$ 1.1b | US$ 1.1b | US$ 75.8m | US$ 10.0m | US$ 5.8b | US$ 6.3b | US$ 1.4b | US$ 7.3b | US$ 1.5b | US$ 0.0m | 12% | 26% | 0.0× | 4.5× | 0% | 53.1× | 6.5× | 2.9 |
| 2024 | US$ 2.4b | US$ 525.7m | US$ 911.3m | US$ 703.5m | US$ 55.8m | US$ 9.3m | US$ 4.6b | US$ 5.0b | US$ 1.2b | US$ 5.9b | US$ 1.3b | US$ 0.0m | 11% | 22% | 0.0× | 4.2× | 0% | 63.4× | 7.2× | 5.6 |